Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 18, Pages 4576
Publisher
MDPI AG
Online
2019-09-17
DOI
10.3390/ijms20184576
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival
- (2019) Zachariah Payne Sellers et al. Clinical Epigenetics
- Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemia
- (2019) Eunice S. Wang BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
- (2019) Swati Garg et al. BLOOD
- Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia
- (2019) Masamitsu Yanada et al. ANNALS OF HEMATOLOGY
- Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo
- (2018) Mira Jeong et al. Cell Reports
- Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia
- (2018) Xin-Yue Lian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
- (2017) Hamid Bolouri et al. NATURE MEDICINE
- Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells
- (2017) Feng Pan et al. Nature Communications
- Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations
- (2017) Anne-Kathrin Garz et al. Oncotarget
- Detection of prognostic methylation markers by methylC-capture sequencing in acute myeloid leukemia
- (2017) Yan Li et al. Oncotarget
- Acute Myeloid Leukemia
- (2017) Margaret R. O'Donnell et al. Journal of the National Comprehensive Cancer Network
- Epigenetic landscape of theTERTpromoter: a potential biomarker for high risk AML/MDS
- (2016) Xin Zhao et al. BRITISH JOURNAL OF HAEMATOLOGY
- Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development
- (2016) Rui Lu et al. CANCER CELL
- Genomic Profiling of Pediatric Acute Myeloid Leukemia Reveals a Changing Mutational Landscape from Disease Diagnosis to Relapse
- (2016) Jason E. Farrar et al. CANCER RESEARCH
- DNA Methylation Dynamics of Human Hematopoietic Stem Cell Differentiation
- (2016) Matthias Farlik et al. Cell Stem Cell
- Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions
- (2016) Sumiyo Morita et al. NATURE BIOTECHNOLOGY
- Quantitative comparison of DNA methylation assays for biomarker development and clinical applications
- (2016) Christoph Bock et al. NATURE BIOTECHNOLOGY
- DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
- (2016) Olga A Guryanova et al. NATURE MEDICINE
- Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
- (2016) Sheng Li et al. NATURE MEDICINE
- Repurposing the CRISPR-Cas9 system for targeted DNA methylation
- (2016) Aleksandar Vojta et al. NUCLEIC ACIDS RESEARCH
- 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
- (2016) Jae-Sook Ahn et al. Oncotarget
- 5-hydroxymethylcytosine loss is associated with poor prognosis for patients with WHO grade II diffuse astrocytomas
- (2016) Feng Zhang et al. Scientific Reports
- Targeting epigenetic pathways in acute myeloid leukemia and myelodysplastic syndrome: a systematic review of hypomethylating agents trials
- (2016) Seongseok Yun et al. Clinical Epigenetics
- DNMT3A and TET2 in the Pre-Leukemic Phase of Hematopoietic Disorders
- (2016) Hanae Sato et al. Frontiers in Oncology
- Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma
- (2016) Xuejiao Shi et al. PLoS One
- Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
- (2015) Paolo Strati et al. AMERICAN JOURNAL OF HEMATOLOGY
- Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy
- (2015) Michael L. Wang et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The hematopoietic stem cell niche in homeostasis and disease
- (2015) L. M. Calvi et al. BLOOD
- Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3-ITD positive acute myeloid leukemia
- (2015) Hamid Ali Nagi Al-Jamal et al. BMC CANCER
- Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia
- (2015) Yan-Fang Tao et al. BMC CANCER
- Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
- (2015) Alan H. Shih et al. CANCER CELL
- Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer
- (2015) Ke Chen et al. CELL RESEARCH
- Loss ofTET2in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis
- (2015) Kasper D. Rasmussen et al. GENES & DEVELOPMENT
- PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia
- (2015) Christopher B. Cole et al. JOURNAL OF CLINICAL INVESTIGATION
- The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
- (2015) E Chang et al. LEUKEMIA
- TET1 is a tumor suppressor of hematopoietic malignancy
- (2015) Luisa Cimmino et al. NATURE IMMUNOLOGY
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute loss of TET function results in aggressive myeloid cancer in mice
- (2015) Jungeun An et al. Nature Communications
- Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice
- (2015) Zhigang Zhao et al. Cell Reports
- DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
- (2015) Tanja Božić et al. Clinical Epigenetics
- Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial
- (2014) Mariam G. Aslanyan et al. ANNALS OF HEMATOLOGY
- Characterization of acute myeloid leukemia based on levels of global hydroxymethylation
- (2014) L. I. Kroeze et al. BLOOD
- A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
- (2014) Mark Kirschbaum et al. BRITISH JOURNAL OF HAEMATOLOGY
- The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
- (2014) David A. Russler-Germain et al. CANCER CELL
- Dnmt3a and Dnmt3b Have Overlapping and Distinct Functions in Hematopoietic Stem Cells
- (2014) Grant A. Challen et al. Cell Stem Cell
- Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated byDNMT3Amutational status and associated with predominant hypomethylation of HOX genes
- (2014) Ying Qu et al. Epigenetics
- Epigenetic regulation of hematopoietic stem cell aging
- (2014) Isabel Beerman et al. EXPERIMENTAL CELL RESEARCH
- Cell signaling pathways involved in hematopoietic stem cell specification
- (2014) Albert D. Kim et al. EXPERIMENTAL CELL RESEARCH
- TET proteins and 5-methylcytosine oxidation in hematological cancers
- (2014) Myunggon Ko et al. IMMUNOLOGICAL REVIEWS
- Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis
- (2014) M R Corces-Zimmerman et al. LEUKEMIA
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Diagnostic Value of DNA Methylation in Leukemia: A Systematic Review and Meta-Analysis
- (2014) Danjie Jiang et al. PLoS One
- Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
- (2013) V. I. Gaidzik et al. BLOOD
- Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma
- (2013) F. Asmar et al. HAEMATOLOGICA
- Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
- (2013) Steven M. Chan et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Functional Specificity of CpG DNA-binding CXXC Domains in Mixed Lineage Leukemia
- (2013) Laurie E. Risner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score
- (2013) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Microsphere-Based Multiplex Analysis of DNA Methylation in Acute Myeloid Leukemia
- (2013) Gerald B.W. Wertheim et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Epigenetic dysregulation of leukaemic HOX code inMLL-rearranged leukaemia mouse model
- (2013) Ray Kit Ng et al. JOURNAL OF PATHOLOGY
- Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
- (2013) H-A Hou et al. LEUKEMIA
- Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia
- (2013) E Jost et al. LEUKEMIA
- Origins of aberrant DNA methylation in acute myeloid leukemia
- (2013) T Schoofs et al. LEUKEMIA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- The role of hypomethylating agents in the treatment of elderly patients with AML
- (2013) Haifa Kathrin Al-Ali et al. Journal of Geriatric Oncology
- Chromatin accessibility, p300, and histone acetylation define PML-RAR and AML1-ETO binding sites in acute myeloid leukemia
- (2012) S. Saeed et al. BLOOD
- DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding
- (2012) T. Schoofs et al. BLOOD
- Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia
- (2012) P. Yan et al. BLOOD
- Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains
- (2012) J. J. Trowbridge et al. GENES & DEVELOPMENT
- Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites
- (2012) A. Hogart et al. GENOME RESEARCH
- Epigenetic regulation of hematopoiesis
- (2012) Goro Sashida et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
- (2012) R Swords et al. LEUKEMIA
- DNA Methylation Dynamics during In Vivo Differentiation of Blood and Skin Stem Cells
- (2012) Christoph Bock et al. MOLECULAR CELL
- TET2andDNMT3AMutations in Human T-Cell Lymphoma
- (2012) Lucile Couronné et al. NEW ENGLAND JOURNAL OF MEDICINE
- Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia
- (2012) Altuna Akalin et al. PLoS Genetics
- Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks
- (2011) S. Deneberg et al. BLOOD
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
- (2011) Wei Xu et al. CANCER CELL
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
- (2011) Kelly Moran-Crusio et al. CANCER CELL
- Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids
- (2011) Lakshminarayan M. Iyer et al. CELL CYCLE
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- Landscape of TET2 mutations in acute myeloid leukemia
- (2011) S Weissmann et al. LEUKEMIA
- Directional DNA Methylation Changes and Complex Intermediate States Accompany Lineage Specificity in the Adult Hematopoietic Compartment
- (2011) Emily Hodges et al. MOLECULAR CELL
- Dnmt3a is essential for hematopoietic stem cell differentiation
- (2011) Grant A Challen et al. NATURE GENETICS
- Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group
- (2011) Phoenix A. Ho et al. PEDIATRIC BLOOD & CANCER
- Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
- (2011) Y.-F. He et al. SCIENCE
- Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
- (2011) S. Ito et al. SCIENCE
- Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies
- (2010) Ulrike Bacher et al. ANNALS OF HEMATOLOGY
- How I treat acute myeloid leukemia
- (2010) J. M. Rowe et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
- (2010) Joost H.A. Martens et al. CANCER CELL
- Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia
- (2010) S Deneberg et al. LEUKEMIA
- CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
- (2010) T-C Lin et al. LEUKEMIA
- Comprehensive methylome map of lineage commitment from haematopoietic progenitors
- (2010) Hong Ji et al. NATURE
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia
- (2010) Sara Alvarez et al. PLoS One
- The implications of heterogeneous DNA methylation for the accurate quantification of methylation
- (2010) Thomas Mikeska et al. Epigenomics
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- Quantitative DNA methylation predicts survival in adult acute myeloid leukemia
- (2009) L. Bullinger et al. BLOOD
- Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
- (2009) T. E. Fandy et al. BLOOD
- DNA Methyltransferase 1 Is Essential for and Uniquely Regulates Hematopoietic Stem and Progenitor Cells
- (2009) Jennifer J. Trowbridge et al. Cell Stem Cell
- DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
- (2009) Lanlan Shen et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- (2009) A Tefferi et al. LEUKEMIA
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction
- (2009) Ann-Marie Bröske et al. NATURE GENETICS
- Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia
- (2009) Tomasz Cierpicki et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition
- (2009) A Lakshmikuttyamma et al. ONCOGENE
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
- (2008) H. Kroeger et al. BLOOD
- Azacytidine causes complex DNA methylation responses in myeloid leukemia
- (2008) C. Stresemann et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now